206 related articles for article (PubMed ID: 18245520)
1. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention.
Parsons JT; Slack-Davis J; Tilghman R; Roberts WG
Clin Cancer Res; 2008 Feb; 14(3):627-32. PubMed ID: 18245520
[TBL] [Abstract][Full Text] [Related]
2. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
Schwock J; Dhani N; Hedley DW
Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction by focal adhesion kinase in cancer.
Zhao J; Guan JL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
[TBL] [Abstract][Full Text] [Related]
4. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
[TBL] [Abstract][Full Text] [Related]
5. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase: a potential target in cancer therapy.
van Nimwegen MJ; van de Water B
Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
[TBL] [Abstract][Full Text] [Related]
7. FAK expression regulation and therapeutic potential.
Li S; Hua ZC
Adv Cancer Res; 2008; 101():45-61. PubMed ID: 19055942
[TBL] [Abstract][Full Text] [Related]
8. Small tyrosine kinase inhibitors as key molecules in the expression of metalloproteinases by solid tumors.
Stahtea XN; Kousidou OCh; Roussidis AE; Tzanakakis GN; Karamanos NK
Connect Tissue Res; 2008; 49(3):211-4. PubMed ID: 18661345
[TBL] [Abstract][Full Text] [Related]
9. Laminin-induced signaling in tumor cells.
Givant-Horwitz V; Davidson B; Reich R
Cancer Lett; 2005 Jun; 223(1):1-10. PubMed ID: 15890231
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesions: paradigm for a signaling nexus.
Romer LH; Birukov KG; Garcia JG
Circ Res; 2006 Mar; 98(5):606-16. PubMed ID: 16543511
[TBL] [Abstract][Full Text] [Related]
11. [Integrins and their role in malignant neoplasm progression].
Błasiak J; Niewiarowska J; Cieślak M; Cierniewski CS
Postepy Biochem; 1999; 45(4):239-48. PubMed ID: 10786368
[No Abstract] [Full Text] [Related]
12. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
13. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
[TBL] [Abstract][Full Text] [Related]
14. The role of cell adhesion pathways in angiogenesis.
Ramjaun AR; Hodivala-Dilke K
Int J Biochem Cell Biol; 2009 Mar; 41(3):521-30. PubMed ID: 18762270
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
[TBL] [Abstract][Full Text] [Related]
16. Targeting protein kinases in cancer therapy: a success?
Pearson MA; Fabbro D
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1113-24. PubMed ID: 15606337
[TBL] [Abstract][Full Text] [Related]
17. Current and future approaches for the therapeutic targeting of metastasis (review).
Germanov E; Berman JN; Guernsey DL
Int J Mol Med; 2006 Dec; 18(6):1025-36. PubMed ID: 17089005
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase as a regulator of cell tension in the progression of cancer.
Tilghman RW; Parsons JT
Semin Cancer Biol; 2008 Feb; 18(1):45-52. PubMed ID: 17928235
[TBL] [Abstract][Full Text] [Related]
19. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.
Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S
Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
